News & Articles

For patients with chronic back or neck pain who have not found relief through conservative care, spinal fusion is not the only option. This guide covers minimally invasive and regenerative alternatives — including intra-annular fibrin injection — and what candidacy evaluation involves.

Epidural steroid injections may reduce inflammation temporarily, but they do not repair disc damage. Intra-annular fibrin injection targets annular tears structurally. Learn how these approaches compare for patients seeking lasting relief from chronic disc-related back pain.

Spinal fusion and intra-annular fibrin injection take opposite approaches to chronic back pain — one permanently stabilizes a segment, the other aims to repair it. Here is how they compare on invasiveness, motion preservation, recovery, and candidacy, and what individual evaluation actually means for your decision.

Chronic discogenic back pain does not always require spinal fusion. Biologic disc repair — including intra-annular fibrin injection — offers a minimally invasive alternative that targets annular tears directly, preserves spinal motion, and avoids surgical hardware. Candidacy is evaluated individually; outcomes vary by case.

Compare laminectomy and regenerative spine care for spinal stenosis — including intra-annular fibrin injection and biologic disc repair — so you can evaluate which path fits your individual situation and ask the right questions before committing to any treatment.

Microdiscectomy and non-surgical disc treatments each address different aspects of disc-related pain, and the right path depends on the individual patient's diagnosis, imaging findings, and treatment history. This guide reviews how each approach works, what risks and limitations to consider, and how candidacy for biologic disc repair is evaluated.

Compare intra-annular fibrin injection to traditional spine surgeries. Explore how each approach works, their risk profiles, recovery expectations, and how candidacy is determined for biologic disc repair.